The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Radiographic-pathologic concordance in the workup of locally radiorecurrent prostate cancer.
 
Luca Faustino Valle
No Relationships to Disclose
 
Jeremie Calais
Honoraria - Advanced Accelerator Applications; EXINI Diagnostics; Progenics; Radiomedix
Consulting or Advisory Role - Blue Earth Diagnostics; Curium Pharma; GE Healthcare; Janssen; Lantheus Medical Imaging; POINT Biopharma; Progenics; Telix Pharmaceuticals
Speakers' Bureau - IBA RadioPharma Solutions; Telix Pharmaceuticals
Research Funding - Progenics
 
Leonard S. Marks
Employment - Avenda Health
Leadership - Avenda Health
 
Steven Raman
No Relationships to Disclose
 
Robert Evan Reiter
Stock and Other Ownership Interests - ImaginAb
Consulting or Advisory Role - Astellas Pharma
Speakers' Bureau - Bayer Schering Pharma; Genomic Health; ImaginAb; Janssen Oncology
Patents, Royalties, Other Intellectual Property - patents surrounding discovery of PSCA and N-cadherin, owned by UCLA (Inst)
 
Matthew Rettig
Leadership - Aravalent; Survalent
Stock and Other Ownership Interests - Oncovalent Therapeutics; Survalent
Consulting or Advisory Role - Ambrx; Amgen; Clovis Oncology; Inmune Bio; Roivant
Speakers' Bureau - Bayer; Johnson & Johnson
Research Funding - Johnson & Johnson (Inst); Medivation/Astellas (Inst); Novartis (Inst); Progenics
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet.
Travel, Accommodations, Expenses - Johnson & Johnson
 
John Shen
Consulting or Advisory Role - AstraZeneca; Bayer; Kite/Gilead; Sanofi
Research Funding - Ambrx (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Exelixis (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Kite/Gilead; Sanofi
 
Johannes Czernin
Employment - SOFIE; Trethera
Leadership - SOFIE; Trethera
Stock and Other Ownership Interests - SOFIE; Trethera
Consulting or Advisory Role - Actinuum; Amgen; Jubilant Radiopharma; POINT Biopharma; RayzeBio
 
Adam B Weiner
No Relationships to Disclose
 
Michael L. Steinberg
Honoraria - Viewray
Consulting or Advisory Role - Viewray
Research Funding - ViewRay
 
Nicholas George Nickols
Consulting or Advisory Role - Oncolinea Pharmaceuticals
Research Funding - Bayer; Janssen Scientific Affairs; Progenics; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I am listed as inventor on patents related to PyIm polyamides that have been licensed by Gene Sciences
 
Albert J Chang
Honoraria - Boston Scientific; Elekta; Natera
Consulting or Advisory Role - Boston Scientific; Varian Medical Systems
Speakers' Bureau - Boston Scientific; Elekta; Natera
Research Funding - AstraZeneca
 
Paul Christopher Boutros
Consulting or Advisory Role - BioSymetrics; Intersect Diagnostics
Patents, Royalties, Other Intellectual Property - Holds patents on multiple biomarkers
 
Huihui Ye
No Relationships to Disclose
 
Masatoshi Hotta
No Relationships to Disclose
 
Rong Rong Huang
No Relationships to Disclose
 
Amar Upadhyaya Kishan
Stock and Other Ownership Interests - ViewRay
Honoraria - Varian Medical Systems; ViewRay; ViewRay
Consulting or Advisory Role - Boston Scientific; Janssen
Research Funding - Janssen Oncology (Inst); Point Biopharma (Inst); ViewRay; ViewRay